www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Industries

Medicine trade tops $100b in 2015

By Wang Wen (China Daily) Updated: 2016-02-05 08:11

Medicine trade tops $100b in 2015

Employees arrange pills at a workshop owned by Beijing Tong Ren Tang Group Co Ltd, a traditional Chinese medicine maker.[Photo/Xinhua]

China's trade in medicines hit an all-time high of $102 billion last year.

The latest figures from the China Chamber of Commerce for Import and Export of Medicines and Health Products show the value was a 4.73 percent increase on 2014, and this year total export-import volumes are expected to rise again, by 3 to 5 percent.

Xu Ming, the chamber's deputy director, called the overall growth "healthy and stable", adding, however, that the Chinese export market had slowed.

Medicine imports were worth $46.2 billion, up 7.3 percent, while exports grew a slower 2.7 percent to $56.4 billion.

"That import growth indicates the Chinese domestic market has huge potential, as it is now the second-largest globally after the United States," said Xu.

The weaker export figures were largely indicative of an ongoing global economic slowdown, Xu said, and coupled with a weaker yuan, they put China on the back foot as an international medicine supplier.

Exports to the US performed well, even though some other main markets dropped. Volumes to the US grew 7.72 percent compared with the previous year and it is now China's second-largest medicine export market after Europe, where demand dropped 0.22 percent.

Xu remains positive that Chinese companies are making strong headway in their moves to expand trade abroad.

Some have been expanding through investment and merger, which is often a more complicated route than simply selling their products directly.

"It's astonishing how some Chinese companies have performed so well in overseas investments," Xu said.

One of the sector's most significant developments in 2015 was by a consortium led by Shanghai Fosun Pharmaceutical Group Co Ltd, which bought Ambrx Inc, a US biotechnology company focusing on molecular medicine.

The acquisition group also involved HOPU Jinghua (Beijing) Investment Consultancy Co Ltd, China Everbright Ltd's healthcare fund, and Wuxi PharmaTech, and the purchase included some valuable global biotechnology.

Fosun Pharma's Chairman Chen Qiyu said the acquisition would "produce a dramatic synergistic effect on Fosun's current development system".

Ambrx is now expected to build a global products development center in China, Chen said.

Other moves saw Chinese companies signing agreements with foreign companies to sell their products overseas.

Jiangsu Heng Rui Medicine Co Ltd, for instance, authorized US-based pharmaceutical company Incyte Corp to develop and sell its PD-1 antibody product outside China in September, with the Delaware firm paying $795 million for the right.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 亚洲成人高清在线观看 | 日本欧美一区二区三区片 | 亚洲成a人片在线观看 欧美 | 国产精品一级片 | 欧美日韩专区国产精品 | 国产精品爱久久久久久久9999 | 亚洲午夜精品久久久久久抢 | 国产美女一区二区三区 | 日本精品久久久久久久久免费 | 日韩综合久久 | 日韩免费一级毛片欧美一级日韩片 | 美女视频免费永久观看的 | 国产精品久久久 | 三级黄a| 国产精品视频九九九 | 国产色手机在线观看播放 | 欧美久 | 欧美在线一区视频 | 欧美三级三级三级爽爽爽 | 在线看国产 | 一级做a爱久久久久久久 | 99久热在线精品视频观看 | 91久久香蕉国产线看 | 欧美怡红院免费全视频 | 色天使色婷婷在线影院亚洲 | 一级毛片真人免费播放视频 | 二级黄的全免费视频 | 国产精品久久福利网站 | aaa一级毛片 | 性刺激久久久久久久久 | 色精品视频 | 国产欧美精品区一区二区三区 | 国产成人久久777777 | 中文字幕一区二区在线观看 | 在线看欧美成人中文字幕视频 | 国产在线精品福利91香蕉 | 性强烈欧美一级毛片 | 成人精品国产亚洲欧洲 | 国产精品亚洲第一区柳州莫青 | 国产成人一区二区三区视频免费 | 欧美色视频日本片免费高清 |